OncoTherapy Science

OncoTherapy Science Overview

Status Public
Employees 73
Employees
Stock Symbol 4564
Stock Symbol
Share Price $1.04 (As of Friday Closing)

OncoTherapy Science General Information

Description

OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Kanagawa
  • Japan
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTherapy Science Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.04 $1.03 $0.48 - $1.29 $182M 176M 6.97M -$0.17

OncoTherapy Science Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018 FY 2017 31-Mar-2017
EV 85,106 136,378 229,977 229,118
Revenue 1,782 2,531 1,906 2,646
EBITDA (25,286) (25,004) (26,854)
Net Income (25,831) (26,471) (25,720) (27,707)
Total Assets 44,685 48,405 75,483 94,742
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ready to get started?

Request a free trial